AC Biotech is a French biotech start-up company headquartered at the Villejuif Bio Park in Paris. The company pursues independent research and development activities and acts at the same time as the oncology competency and development centre for its sister company AC Bioscience SA.
Founded by Professor Christian Auclair and Andreas Schläpfer in December 2016, the company is leading a paradigm shift in hypoxic cancer therapeutics.
The company’s primary focus is on clinical validation of its first-in-man angiogenic therapy in metastatic pancreatic cancer (mPAC) patients.
Co-Founder
Extensive experience in business strategy and global management, gained from over 30 years in senior executive positions at Nestle (including PDG Nestle France from 2001-2004)
President of AC BioTech and Chief Medical Officer
Specializing in Oncology and Cancer Biology. Previously CMO at Hybrigenics and Head of Clinical Development at Bioalliance.
Co-Founder and CSO
An eminent expert in pharmacology, molecular oncology and innate immunity (PharmD, PhD). Emeritus professor. Advisor to public biotech company AB Science.
Senior Scientific Officer - Oncology
Obtained a Ph.D. in molecular and cellular oncology from the University of Paris Sud/ENS Paris Saclay followed by an extensive research training at Harvard Medical School in cancer biology and therapeutics.
Pharm D - CMC Manager
A highly experienced CMC expert previously Head of Pharmaceutical Development/CMC and Pharmaceutical Operations at AB Science.
Legal and Compliance Advisor
A former General Counsel and Chief Compliance Officer for multinational corporate and private investment mandates. She holds Master's in Economics and Juris Doctorate, University of Denver.
Jean Baptiste Bachet, PhD
Professor and Head of the digestive oncology unit in the Hepato-Gastroenterology department at Hôpital Pitié-Salpêtrière – Assistance Publique Hôpitaux de Paris, Sorbonne Universités.
Patrick Couvreur, PhD
Member of the Academy of Sciences and Professor, Paris-Sud University / CNRS, pharmacist, specializing in medical nanotechnologies.
Jean-Pierre Kinet, MD
Former Professor of Pathology at Harvard Medical School and globally recognized expert in immunology.
Olivier Hermine, PhD
Professor of Hematology, Paris Descartes University, and Head of Hematology Department, Necker Children's Hospital, Paris
Marco Cuifolini, PhD
Former Professor and Head of Department of Chemistry, Faculty of Science of the University of British Columbia, Vancouver, Canada.